Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid.
Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid.
复制标题
孤儿核受体小异二聚体伴侣配体和凋亡诱导剂 (E)-4-[3-(1-金刚烷基)-4-羟基苯基]-3-氯肉桂酸的杂原子取代类似物。
DOI:
10.1021/jm200051z
复制
发表时间:
2011
影响因子:
7.3
通讯作者:
Dawson,MarciaI
中科院分区:
文献类型:
--
作者:
Xia,Zebin;Farhana,Lulu;Correa,RicardoG;Das,JayantaK;Castro,DavidJ;Yu,Jinghua;Oshima,RobertG;Reed,JohnC;Fontana,JosephA;Dawson,MarciaI
(E)-4-[3′-(1-Adamantyl)-4′-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) induces the cell cycle arrest and apoptosis of cancer cells. Because its pharmacologic propertiessolubility, bioavailability, and toxicityrequired improvement for translation, structural modifications were made by introducing nitrogen atoms into the cinnamyl ring and replacing itsE-double bond with XCH2(X = O, N, and S) with the objective of enhancing these properties without impacting apoptosis-inducing activity. Analogues having nitrogen atoms in heterocyclic rings corresponding to the cinnamyl phenyl ring displayed equal or higher biological activities. The pyrimidine and pyridine analogues were more soluble in both phosphate-buffered saline and water. While the 2,5-disubstituted pyridine analogue was the most potent inducer of KG-1 acute myeloid leukemia cell apoptosis, on the basis of apoptotic activity in KG-1 cells and solubility, the 2,5-disubstituted pyrimidine proved to be the more promising candidate for treatment of acute myeloid leukemia.